Beck Capital Management’s Teladoc Health TDOC Stock Holding History

Beck Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,014	Closed	-$312K	–	97
2020 Q1	$312K	Buy	+2,014	New	+$234K	0.29%	51

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Beck Capital Management's TDOC Position: Q2 2020 in Review

Beck Capital Management sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 2,014 shares — an estimated $312K sold.

Beck Capital Management first reported a position in TDOC in Q1 2020 and held it in 1 quarter. The position peaked at $312K in Q1 2020. 669 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Beck Capital Management reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
Beck Capital Management sold 2,014 Teladoc Health shares in Q2 2020, an estimated $312K.
Beck Capital Management first reported a position in Teladoc Health in Q1 2020 and held it in 1 quarter.
Beck Capital Management's Teladoc Health position peaked at $312K in Q1 2020.
669 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Beck Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.